Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Garden State Dispatch.
Press releases published on October 24, 2025
'The Rewrite' Explores Rapid Healing, Energy, and Mindset with Vibrational Energy Coach Mary Petto
NJ, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- In a recent episode of The Rewrite, host Wendy Sloan sits down with Mary Petto, a vibrational energy coach, rapid turmoil resolution specialist, and author of The Family Guide to the Law of …
NCJAR Volunteers Join Habitat for Humanity to Build Homes and Hope in Rockaway, NJ
NCJAR volunteers joined Habitat for Humanity in Rockaway, NJ, on Oct 17, 2025, to help build safe, affordable homes for families in need. MORRISTOWN, NJ, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- On October 17, 2025, nine dedicated members …
New Jersey Personal Injury Attorney Douglas Standriff Explains How Pain and Suffering Damages Are Calculated in 2025
How Pain and Suffering Is Calculated in New Jersey: The Formula Bergen County Courts Actually Use MAYWOOD, NJ, UNITED STATES, October 24, 2025 /EINPresswire.com/ -- Bergen Law Managing Partner Douglas Standriff, Esq., a Certified Civil Trial Attorney …
Enzon and Viskase Announce Amendment to Merger Agreement
CRANFORD, N.J. and LOMBARD, Ill., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or the “Company”) and Viskase Companies, Inc. (OTC Pink Limited: VKSC) (“Viskase”) today announced that they have entered into an …
Middlesex Water Company Increases Common Dividend by 5.88%
ISELIN, N.J., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Middlesex Water Company (NASDAQ: MSEX) announced today that its Board of Directors has declared a quarterly cash dividend of $0.36 per share on its common stock, a 5.88% increase from the $0.34 per share …
PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Data presented today as an oral presentation at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Confirmed responses observed in eight tumor types spanning ovarian, lung, breast, endometrial, head and neck, …